Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.425 USD | +0.57% | +3.26% | +146.67% |
Mar. 22 | H.C. Wainwright Adjusts Price Target on Pyxis Oncology to $7 From $4, Maintains Buy Rating | MT |
Mar. 21 | Health Care Up on Drug Sales Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+146.67% | 259M | |
-1.56% | 104B | |
+6.57% | 97.47B | |
+5.71% | 22.25B | |
-12.88% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.82% | 16.36B | |
+8.28% | 14.39B | |
+36.50% | 12.37B |
- Stock Market
- Equities
- PYXS Stock
- News Pyxis Oncology, Inc.
- Pyxis Oncology Shares Fall After CEO Sells Stock